Company Filing History:
1 out of 154 
1 out of 1,743 
1 out of 3 Years Active: 2025
Title: Marvin Lerousseau: Innovator in Cancer Prediction Technology
Introduction
Marvin Lerousseau is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer research through his innovative patent. His work focuses on developing methods and devices that enhance the prediction of cancer relapse, which is crucial for patient care and treatment planning.
Latest Patents
Marvin Lerousseau holds a patent for a device and method designed to predict the risk of cancer relapse in patients. This invention involves a prediction model that utilizes whole histological slide images, which include representations of cancerous tissue. The trained prediction model not only assesses the risk of relapse but also predicts the patient's response to cancer treatment.
Career Highlights
Throughout his career, Marvin has worked with prestigious institutions such as Institut Curie and the Institut National de la Santé et de la Recherche Médicale. His experience in these organizations has allowed him to collaborate with leading experts in the field of oncology and medical research.
Collaborations
Marvin has collaborated with notable colleagues, including Thomas Walter and Anne Vincent-Salomon. These partnerships have contributed to the advancement of his research and the development of his innovative solutions in cancer prediction.
Conclusion
Marvin Lerousseau's work exemplifies the intersection of technology and healthcare, particularly in the fight against cancer. His innovative patent and collaborations with esteemed institutions highlight his commitment to improving patient outcomes through advanced predictive methods.